| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AJT.14466 |
| P698 | PubMed publication ID | 28805293 |
| P50 | author | Didier A Mandelbrot | Q88724038 |
| P2093 | author name string | Arjang Djamali | |
| Thomas M Ellis | |||
| Sandesh Parajuli | |||
| Patrick K Reville | |||
| P2860 | cites work | Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial | Q46825301 |
| Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. | Q46972639 | ||
| Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules | Q47272995 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| De Novo Donor-Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis | Q48955987 | ||
| De Novo Anti-HLA DSA Characteristics and Subclinical Antibody-Mediated Kidney Allograft Injury. | Q50276822 | ||
| The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss. | Q51010023 | ||
| Kidney Intragraft Homing of De Novo Donor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but Not Per Se Predictive of Graft Loss. | Q51585363 | ||
| Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody. | Q53459320 | ||
| OPTN/SRTR 2015 Annual Data Report: Early effects of the new kidney allocation system | Q31152692 | ||
| Does subclinical rejection contribute to chronic rejection in renal transplant patients? | Q33806988 | ||
| Quantifying renal allograft loss following early antibody-mediated rejection. | Q35007419 | ||
| Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts | Q35790552 | ||
| Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients | Q36030401 | ||
| Donor-specific antibodies adversely affect kidney allograft outcomes. | Q36426146 | ||
| Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. | Q37453921 | ||
| Interpretation of HLA single antigen bead assays | Q38129992 | ||
| Nature, timing, and severity of complications from ultrasound-guided percutaneous renal transplant biopsy | Q38568952 | ||
| Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function | Q39765166 | ||
| Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure | Q40386334 | ||
| Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss | Q40634986 | ||
| Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts | Q45287212 | ||
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3210-3218 | |
| P577 | publication date | 2017-08-14 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Utility of protocol kidney biopsies for de novo donor-specific antibodies. | |
| P478 | volume | 17 |
| Q90117060 | Blessing and a curse of outpatient management of delayed graft function |
| Q93050097 | Comparison of a time-varying covariate model and a joint model of time-to-event outcomes in the presence of measurement error and interval censoring: application to kidney transplantation |
| Q61946036 | Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant |
| Q92803508 | Donor-Specific Antibodies in the Absence of Rejection Are Not a Risk Factor for Allograft Failure |
| Q57489318 | Influence of HLA-DQ Matching on Allograft Outcomes in Deceased Donor Kidney Transplantation |
Search more.